Top 3 caprelsarems.com competitors & alternatives
[CAPRELSA® (vandetanib) REMS Program | Advanced Medullary Thyroid Carcinoma (MTC) Information for the CAPRELSA REMS Program. CAPRELSA® (vandetanib), a kinase inhibitor, approved by the FDA for symptomatic or progressive medullary thyroid cancer treatment in patients with unresectable locally advanced or metastatic disease.]
caprelsarems.com competitors and alternatives
Top 3 caprelsarems.com competitors and alternatives are ranked by similar search terms, traffic and worth.
caprelsarems.com's top 5 competitors are: caprelsa.com with 0 daily traffic and 7,200 estimated worth, vandetanibrems.com with 2,000 daily traffic and 27,000 estimated worth, checkyourneck.com with 50 daily traffic and 9,600 estimated worth,
caprelsa.com
CAPRELSA (vandetanib) Tablets
Indication and Usage | CAPRELSA is a prescription medicine used to treat medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body, and the tumors are growing or causing symptoms. Because of the risks associated with CAPRELSA, your health care provider should carefully consider whether to prescribe CAPRELSA for you if your tumors are growing slowly or if you are not having symptoms.
Daily Traffic: 0
Website Worth: $ 7,200
vandetanibrems.com
CAPRELSA (vandetanib) REMS Program | Advanced Medullary Thyroid Carcinoma (MTC) | caprelsarems.com
Information on CAPRELSA (vandetanib), a kinase inhibitor, approved by the FDA for symptomatic or progressive medullary thyroid cancer treatment in patients with unresectable locally advanced metastatic disease.
Daily Traffic: 2,000
Website Worth: $ 27,000
Share on Social Media
Similar sites like caprelsarems.com